The iron chelator Dp44mT causes DNA damage and selective inhibition of topoisomerase IIalpha in breast cancer cells.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Cancer Research

• Publication date

  2009-02-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1158/0008-5472.CAN-08-1437PMID 19176392PMCID PMC7322628
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of iron acquisition and storage: consequences for iron-linked disorders

  2008cited by this paper
• A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells

  2008cited by this paper
• NK314, a Topoisomerase II Inhibitor That Specifically Targets the α Isoform*

  2008cited by this paper
• A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas

  2008cited by this paper
• Endogenous γ-H2AX-ATM-Chk2 Checkpoint Activation in Bloom's Syndrome Helicase–Deficient Cells Is Related to DNA Replication Arrested Forks

  2007cited by this paper
• Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management

  2007cited by this paper
• Batracylin (NSC 320846), a dual inhibitor of DNA topoisomerases I and II induces histone gamma-H2AX as a biomarker of DNA damage.

  2007cited by this paper
• Tuning Cell Cycle Regulation with an Iron Key

  2007cited by this paper
• Iron chelation and regulation of the cell cycle: 2 mechanisms of posttranscriptional regulation of the universal cyclin-dependent kinase inhibitor p21CIP1/WAF1 by iron depletion.

  2007cited by this paper
• Coordination chemistry and biology of chelators for the treatment of iron overload disorders.

  2007cited by this paper
• Topoisomerase IIbeta mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane.

  2007influential reference
• Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies

  2007cited by this paper
• Iron chelation regulates cyclin D1 expression via the proteasome: a link to iron deficiency-mediated growth suppression.

  2007cited by this paper
• Dexrazoxane: how it works in cardiac and tumor cells. Is it a prodrug or is it a drug?

  2007cited by this paper
• The DNA damage response: ten years after.

  2007cited by this paper
• Topoisomerase I inhibitors: camptothecins and beyond

  2006cited by this paper
• The role of iron regulatory proteins in mammalian iron homeostasis and disease

  2006cited by this paper
• Chelators at the Cancer Coalface: Desferrioxamine to Triapine and Beyond

  2006cited by this paper
• A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics

  2006influential reference
• Defective Mre11-dependent Activation of Chk2 by Ataxia Telangiectasia Mutated in Colorectal Carcinoma Cells in Response to Replication-dependent DNA Double Strand Breaks*

  2006cited by this paper
• Structure/function overview of proteins involved in iron storage and transport.

  2005cited by this paper
• Phosphorylation of BLM, dissociation from topoisomerase IIIalpha, and colocalization with gamma-H2AX after topoisomerase I-induced replication damage.

  2005cited by this paper
• Combining Etoposide and Dexrazoxane Synergizes with Radiotherapy and Improves Survival in Mice with Central Nervous System Tumors

  2005cited by this paper
• Tachpyridine, a metal chelator, induces G2 cell-cycle arrest, activates checkpoint kinases, and sensitizes cells to ionizing radiation.

  2005cited by this paper
• Desferal inhibits breast tumor growth and does not interfere with the tumoricidal activity of doxorubicin.

  2005cited by this paper
• Iron chelators in cancer chemotherapy.

  2004cited by this paper
• Cell cycle arrest at the initiation step of human chromosomal DNA replication causes DNA damage

  2004cited by this paper
• Novel di-2-pyridyl-derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessment.

  2004cited by this paper
• Apoptotic Topoisomerase I-DNA Complexes Induced by Staurosporine-mediated Oxygen Radicals*

  2004cited by this paper
• Potent Antitumor Activity of Novel Iron Chelators Derived from Di-2-Pyridylketone Isonicotinoyl Hydrazone Involves Fenton-Derived Free Radical Generation

  2004cited by this paper
• Characteristics of gamma-H2AX foci at DNA double-strand breaks sites.

  2003cited by this paper
• Enforced cytokinesis without complete nuclear division in embryonic cells depleting the activity of DNA topoisomerase IIα

  2003cited by this paper
• ATM and related protein kinases: safeguarding genome integrity

  2003influential reference
• Characteristics of γ-H2AX foci at DNA double-strand breaks sites

  2003cited by this paper
• DNA strand breaks induced by the anti-topoisomerase II bis-dioxopiperazine ICRF-193.

  2003cited by this paper
• Cellular roles of DNA topoisomerases: a molecular perspective

  2002cited by this paper
• Novel "hybrid" iron chelators derived from aroylhydrazones and thiosemicarbazones demonstrate selective antiproliferative activity against tumor cells.

  2002cited by this paper
• DNA topoisomerases: structure, function, and mechanism.

  2001cited by this paper
• Inhibition of malignant cell growth by 311, a novel iron chelator of the pyridoxal isonicotinoyl hydrazone class: effect on the R2 subunit of ribonucleotide reductase.

  2001cited by this paper
• The catalytic DNA topoisomerase II inhibitor dexrazoxane (ICRF-187) induces differentiation and apoptosis in human leukemia K562 cells.

  2001cited by this paper
• Triapine (3-aminopyridine-2-carboxaldehyde- thiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity.

  2000cited by this paper
• Failure of iron chelators to reduce tumor growth in human neuroblastoma xenografts.

  1998cited by this paper
• Preclinical models of cardiac protection and testing for effects of dexrazoxane on doxorubicin antitumor effects.

  1998cited by this paper
• Preclinical models of cardiac protection and testing for effects of dexrazoxane on doxorubicin antitumor effects.

  1998cited by this paper
• A QSAR study comparing the cytotoxicity and DNA topoisomerase II inhibitory effects of bisdioxopiperazine analogs of ICRF-187 (dexrazoxane).

  1995cited by this paper
• Neuroblastoma sensitivity to growth inhibition by deferrioxamine: evidence for a block in G1 phase of the cell cycle.

  1993cited by this paper
• Different patterns of gene expression of topoisomerase II isoforms in differentiated tissues during murine development.

  1992cited by this paper
• Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the "comet" assay.

  1990cited by this paper
• Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines.

  1990cited by this paper
• A simple technique for quantitation of low levels of DNA damage in individual cells.

  1988cited by this paper
• Continual presence of oxygen and iron required for mammalian ribonucleotide reduction: possible regulation mechanism.

  1983cited by this paper
• Transferrin and transferrin receptors in carcinoma of the breast.

  1980cited by this paper

• Thiosemicarbazones as Ion Chelators: Unveiling Their Coordination and Multifaceted Applications

  2025cites this paper
• Pyridine Thiosemicarbazones as Anticancer and Antimicrobial Agents: A Promising Class of Low‐Toxicity Therapeutics

  2025cites this paper
• Thiosemicarbazones down-regulate N-Myc expression in neuroblastoma cells via transcriptional and post-transcriptional mechanisms.

  2025cites this paper
• Topoisomerase II Inhibition in Cancer: A Focus on Metal Complexes.

  2025cites this paper
• Novel synthesis and anticancer screening of indole substituted thiosemicarbazone against HeLa, HCT-15 and U87-MG

  2025cites this paper
• Mechanistic insights into the antiproliferative effect of the redox-active iron chelator Dp44mT on multiple myeloma cell lines

  2025cites this paper
• Iron metabolism in breast cancer: mechanisms and therapeutic implications: a narrative review

  2025cites this paper
• Integrating ensemble machine learning and multi-omics approaches to identify Dp44mT as a novel anti-Candida albicans agent targeting cellular iron homeostasis

  2025cites this paper
• Unanticipated Reactivity toward Nucleophilic Attack in the Synthesis of Saccharyl-1,3,4-Thiadiazolyl Conjugates: Structure and Mechanistic Insights

  2025cites this paper
• Anticancer activity of new water-soluble sulfonated thiosemicarbazone copper(II) complexes targeting disulfide isomerase.

  2024cites this paper
• Synthesis and Comprehensive Characterization with Anticancer Activity Assessment of Salicylaldehyde and 2-Acetylphenol Based Chitosan Thiosemicarbazones and Their Copper(II) Complexes

  2024cites this paper
• Innovative N-Acridine Thiosemicarbazones and Their Zn(II) Complexes Transmetallate with Cu(II): Redox Activity and Suppression of Detrimental Oxy-Myoglobin Oxidation.

  2024cites this paper
• Bio-molecular Fe(III) and Zn(II) complexes stimulate the interplay between PI3K/AKT1/EGFR inhibition and induce autophagy and apoptosis in epidermal skin cell cancer.

  2024cites this paper
• Targeting lysosomes by design: novel N-acridine thiosemicarbazones that enable direct detection of intracellular drug localization and overcome P-glycoprotein (Pgp)-mediated resistance

  2024cites this paper
• The role of cyclin-dependent kinase inhibitor 3 in the proliferation and migration of renal cell carcinoma.

  2024cites this paper
• Differential transmetallation of complexes of the anti-cancer thiosemicarbazone, Dp4e4mT: effects on anti-proliferative efficacy, redox activity, oxy-myoglobin and oxy-hemoglobin oxidation

  2023cites this paper
• Inhibition of Topoisomerases by Metal Thiosemicarbazone Complexes

  2023cites this paper
• Design, Synthesis, Characterization, and Anti-Cancer Activity Evaluation of Novel Thiosemicarbazide Analogs

  2023cites this paper
• Synthesis, characterization, and anticancer activity of chitosan functionalized isatin based thiosemicarbazones, and their copper(II) complexes.

  2023cites this paper
• Study on the Mitochondrial Autophagy Pathway of Apoptosis Induced by Deferoxamine in the Leukemia Cell Line HL-60

  2022cites this paper
• The coordination modes of (thio)semicarbazone copper(II) complexes strongly modulate the solution chemical properties and mechanism of anticancer activity.

  2022cites this paper
• Advances in thiosemicarbazone metal complexes as anti-lung cancer agents

  2022cites this paper
• Role of Iron in Aging Related Diseases

  2022cites this paper
• Pyridine-Based NNS Tridentate Chitosan Thiosemicarbazones and Their Copper(II) Complexes: Synthesis, Characterization, and Anticancer Activity

  2022cites this paper
• Thiosemicarbazones Can Act Synergistically with Anthracyclines to Downregulate CHEK1 Expression and Induce DNA Damage in Cell Lines Derived from Pediatric Solid Tumors

  2022cites this paper
• Puzzling Out Iron Complications in Cancer Drug Resistance.

  2022cites this paper
• Exploring Synthesis and Chemotherapeutic Potential of Thiosemicarbazide Analogs.

  2022cites this paper
• The Impact of Iron Chelators on the Biology of Cancer Stem Cells

  2021cites this paper
• Emerging role of ferroptosis in breast cancer: New dawn for overcoming tumor progression.

  2021cites this paper
• Synthesis and Application of Nanomaterials for Biomedical Anticancer Therapy

  2021cites this paper
• Engineering the early bone metastatic niche through human vascularized immuno bone minitissues

  2021cites this paper
• A Novel Ferroptosis-Related Gene Signature Predicts Overall Survival of Breast Cancer Patients

  2021cites this paper
• Reversing oncogenic transformation with iron chelation

  2021cites this paper
• Mitochondrial mutations and mitoepigenetics: focus on regulation of oxidative stress-induced responses in breast cancers.

  2020cites this paper
• Effects of Iron Chelation in Osteosarcoma.

  2020cites this paper
• Novel Thiosemicarbazones Sensitize Pediatric Solid Tumor Cell-Types to Conventional Chemotherapeutics through Multiple Molecular Mechanisms

  2020cites this paper
• Tumor Targeted Delivery of an Anti‐Cancer Therapeutic: An In Vitro and In Vivo Evaluation

  2020cites this paper
• Complex formation and cytotoxicity of Triapine derivatives: a comparative solution study on the effect of the chalcogen atom and NH-methylation.

  2020cites this paper
• Targeting ferroptosis in breast cancer

  2020cites this paper
• Iron chelators in cancer therapy

  2020cites this paper
• Unique targeting of androgen‐dependent and ‐independent AR signaling in prostate cancer to overcome androgen resistance

  2020cites this paper
• Iron chelation inhibits mTORC1 signaling involving activation of AMPK and REDD1/Bnip3 pathways

  2020cites this paper
• Large–scale screening of molecules involved in virus–host interaction by specific compounds in Cherax quadricarinatus hematopoietic tissue cells

  2020cites this paper
• In vitro and in vivo anticancer activity of tridentate thiosemicarbazone copper complexes: Unravelling an unexplored pharmacological target.

  2020cites this paper
• Dp44mT, an iron chelator, suppresses growth and induces apoptosis via RORA-mediated NDRG2-IL6/JAK2/STAT3 signaling in glioma

  2020cites this paper
• Iron alters Ca2+ homeostasis in doxorubicin‐resistant K562 cells

  2020cites this paper
• Thiosemicarbazones as a Potent Anticancer Agents and Their Modes of Action.

  2020cites this paper
• Anticancer activity of the thiosemicarbazones that are based on di-2-pyridine ketone and quinoline moiety.

  2019cites this paper
• Therapeutic effect of deferrioxamine conjugated to PEGylated gold nanoparticles and complexed with Mn(II) beside the CT scan and MRI diagnostic studies

  2019cites this paper
• DIBI, a novel 3-hydroxypyridin-4-one chelator iron-binding polymer, inhibits breast cancer cell growth and functions as a chemosensitizer by promoting S-phase DNA damage

  2019influential citation
• Synergistic inhibition of tumor cell proliferation by metformin and mito-metformin in the presence of iron chelators

  2019cites this paper
• Anticancer Thiosemicarbazones: Chemical Properties, Interaction with Iron Metabolism, and Resistance Development

  2018cites this paper
• Iron in the Tumor Microenvironment—Connecting the Dots

  2018cites this paper
• Sprayable Adhesive Nanotherapeutics: Mussel-Protein-Based Nanoparticles for Highly Efficient Locoregional Cancer Therapy.

  2018cites this paper
• Gallium(III) complexes of α-N-heterocyclic piperidylthiosemicarbazones: Synthesis, structure-activity relationship, cellular uptake and activation of caspases-3/7/9.

  2018cites this paper
• Structural and Metal Ion Effects on Human Topoisomerase IIα Inhibition by α-(N)-Heterocyclic Thiosemicarbazones.

  2018cites this paper
• Synthesis, antiproliferative activity and mechanism of gallium(III)-thiosemicarbazone complexes as potential anti-breast cancer agents.

  2018cites this paper
• The role of oxidative stress in activity of anticancer thiosemicarbazones

  2018cites this paper
• Piperidylthiosemicarbazones Cu(II) complexes with a high anticancer activity by catalyzing hydrogen peroxide to degrade DNA and promote apoptosis.

  2018cites this paper
• Immune-relevant aspects of murine models of head and neck cancer

  2018cites this paper
• Nrf2 induces cisplatin resistance via suppressing the iron export related gene SLC40A1 in ovarian cancer cells.

  2017cites this paper
• Synergy of Iron Chelators and Therapeutic Peptide Sequences Delivered via a Magnetic Nanocarrier

  2017cites this paper
• Nrf2 induces cisplatin resistance via suppressing the iron export related gene SLC40A1 in ovarian cancer cells

  2017cites this paper
• Synthesis, crystal structure and antiproliferative mechanisms of 2-acetylpyridine-thiosemicarbazones Ga(III) with a greater selectivity against tumor cells.

  2017cites this paper
• Novel 2-pyridinecarboxaldehyde thiosemicarbazones Ga(III) complexes with a high antiproliferative activity by promoting apoptosis and inhibiting cell cycle.

  2017cites this paper
• A novel hydroxyphenyl hydrazone derivate YCL0426 inhibits cancer cell proliferation through sequestering iron

  2017cites this paper
• Human topoisomerase IB is a target of a thiosemicarbazone copper(II) complex.

  2016cites this paper
• α(N)-Heterocyclic Thiosemicarbazones: Iron Chelators that are Promising for Revival of Gallium in Cancer Chemotherapy.

  2016cites this paper
• Mechanism of the induction of endoplasmic reticulum stress by the anti-cancer agent, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT): Activation of PERK/eIF2α, IRE1α, ATF6 and calmodulin kinase.

  2016cites this paper
• Letter to the Editor: “Analysis of the Interaction of Dp44mT with Human Serum Albumin and Calf Thymus DNA Using Molecular Docking and Spectroscopic Techniques”

  2016cites this paper
• Roads to melanoma: Key pathways and emerging players in melanoma progression and oncogenic signaling.

  2016cites this paper
• The novel thiosemicarbazone, di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone (DpC), inhibits neuroblastoma growth in vitro and in vivo via multiple mechanisms

  2016cites this paper
• Phenanthriplatin Acts As a Covalent Poison of Topoisomerase II Cleavage Complexes.

  2016cites this paper
• Turning the gun on cancer: Utilizing lysosomal P-glycoprotein as a new strategy to overcome multi-drug resistance.

  2016cites this paper
• Lysosomal membrane stability plays a major role in the cytotoxic activity of the anti-proliferative agent, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT).

  2016cites this paper
• Analysis of the Interaction of Dp44mT with Human Serum Albumin and Calf Thymus DNA Using Molecular Docking and Spectroscopic Techniques

  2016cites this paper
• Copper enriches efficacy of Dp44mT in breast cancer cells

  2016cites this paper
• MIMICKING AND TARGETING BIOLOGICAL MEMBRANES USING GIANT PROTEOLIPOSOME AND POLYMERIC NANOPARTICLES

  2016influential citation
• Thiosemicarbazones Target Multiple Resistance Pathways in Cancer

  2016cites this paper
• Redox cycling metals: Pedaling their roles in metabolism and their use in the development of novel therapeutics.

  2016cites this paper
• Developing Anticancer Ferric Prodrugs Based on the N-Donor Residues of Human Serum Albumin Carrier IIA Subdomain.

  2016cites this paper
• Modulation of iron metabolism by iron chelation regulates intracellular calcium and increases sensitivity to doxorubicin.

  2015cites this paper
• The antitumor mechanism of di-2-pyridylketone 2-pyridine carboxylic acid hydrazone and its copper complex in ROS generation and topoisomerase inhibition, and hydrazone involvement in oxygen-catalytic iron mobilization.

  2015cites this paper
• The Eltrombopag antitumor effect on hepatocellular carcinoma

  2015cites this paper
• Synthesis of four binuclear copper(II) complexes: Structure, anticancer properties and anticancer mechanism.

  2015cites this paper
• Noble metals in medicine: Latest advances

  2015cites this paper
• Trypanotoxic activity of thiosemicarbazone iron chelators.

  2015cites this paper
• The renaissance of polypharmacology in the development of anti-cancer therapeutics: Inhibition of the "Triad of Death" in cancer by Di-2-pyridylketone thiosemicarbazones.

  2015cites this paper
• Di-2-pyridylketone 4,4-Dimethyl-3-thiosemicarbazone (Dp44mT) Overcomes Multidrug Resistance by a Novel Mechanism Involving the Hijacking of Lysosomal P-Glycoprotein (Pgp)*

  2015cites this paper
• Anti-cancer implications of small molecule compounds targeting proliferating cell nuclear antigen

  2014cites this paper
• The Anticancer Agent Di-2-pyridylketone 4,4-Dimethyl-3-thiosemicarbazone (Dp44mT) Overcomes Prosurvival Autophagy by Two Mechanisms

  2014cites this paper
• Molecular and Cellular Pathobiology IRP 2 Regulates Breast Tumor Growth

  2014cites this paper
• Hormone responsive breast cancer and BRCA1 mutation: mechanism, regulation and iron-mediated effects.

  2014cites this paper
• Effects of iron depletion on CALM-AF10 leukemias.

  2014cites this paper
• Complex forming competition and in-vitro toxicity studies on the applicability of di-2-pyridylketone-4,4,-dimethyl-3-thiosemicarbazone (Dp44mT) as a metal chelator.

  2014cites this paper
• Cytotoxicity and topoisomerase I/II inhibition activity of novel 4-aryl/alkyl-1-(piperidin-4-yl)-carbonylthiosemicarbazides and 4-benzoylthiosemicarbazides

  2014cites this paper
• Iron homeostasis in breast cancer.

  2014cites this paper
• Mechanistic insight of drug resistance with special focus on iron in estrogen receptor positive breast cancer.

  2014cites this paper
• IRP2 regulates breast tumor growth.

  2014cites this paper
• Iron chelating strategies in systemic metal overload, neurodegeneration and cancer.

  2014cites this paper